Archive

Posts Tagged ‘CBER’

Materials Available from FDA Basics Webinar on FDA’s role in ensuring the safety of the nation’s blood supply

March 8, 2011 4 comments

Did you miss the FDA Basics webinar about FDA’s vital role in ensuring the safety of the nation’s blood supply? You can learn about FDA’s five overlapping layers of blood safety and review rules that are designed to make sure we have a safe and available blood supply, including rules related to donor screening and testing of blood for blood-borne infectious agents.

Materials from the webinar are now available. We have posted a link to view and listed to 30 minute webinar and posted a link to download a copy of the presentation slides.

You can also find materials from past FDA Basics webinars.

Upcoming Event: Did you know that FDA plays a vital role in ensuring the safety of the nation’s blood supply?

February 10, 2011 30 comments

As part of FDA Basics, FDA is hosting a webinar where you can learn more FDA’s role in ensuring the safety of the nation’s blood supply.  The featured speaker, Richard Davey, MD, Director of the Division of Blood Applications, Office of Blood Research and Review in FDA’s Center for Biologics Evaluation and Research, will discuss how the agency safeguards the nation’s blood supply and protects the five million people who receive blood transfusions annually. Dr. Davey will provide an overview of these safeguards and will focus on the donor screening process and the testing of blood for blood-borne infectious agents.  After the presentation, there will an opportunity to ask questions.

The free 30 minute webinar will be held Tuesday, February 15th, at 2 p.m. ET.

There are a limited number of spots available for the webinar. Materials from the webinar will also be available on the FDA web site.

Click here for more information about the webinar, including instructions about how to join the webinar.

Ann Witt, Transparency Initiative Coordinator

Upcoming Event: FDA Basics Webinar on FDA’s Safety Monitoring of Approved Vaccines, Tuesday, July 13, 2 p.m. ET

July 8, 2010 3 comments

Did you know that FDA’s review of vaccine safety doesn’t stop once a vaccine is approved?  Why is it important to have different types of systems to perform safety surveillance for approved vaccines?

As part of FDA Basics, FDA is hosting a webinar where you can learn more.  The featured speaker, Andrea Sutherland, MD, MPH, Msc, a medical officer in the Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, will give an overview about vaccine safety surveillance, including the Vaccine Adverse Event Reporting System (or VAERS), and efforts underway to improve safety monitoring.  After the presentation, there will an opportunity to ask questions.

The free 30 minute webinar will be held on Tuesday, July 13, at 2 p.m. ET.

For more information about the webinar, including instructions about how to join the webinar, click here.

There are a limited number of spots available for the webinar.  Webinar materials will be posted on the FDA Web site.

Afia Asamoah, Transparency Initiative Coordinator 

Follow

Get every new post delivered to your Inbox.

Join 173 other followers

%d bloggers like this: